BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Xencor 

111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Discovery





 Company News
Xencor Receives Milestone Payment From Merck & Co., Inc. (MRK) For Initiation Of Phase 1 Clinical Trial Of A Biologic Candidate Using XmAb® Antibody Engineering Intellectual Property 4/11/2014 9:12:31 AM    More...
Xencor Showcases Bispecific Antibody Programs At Annual Summit On Practical And Emerging Trends In Multiple Myeloma 3/28/2014 9:16:47 AM    More...
Xencor Reports Fourth Quarter And Full Year 2013 Financial Results 3/20/2014 6:11:53 AM    More...
Xencor To Host Fourth Quarter And Full Year 2013 Financial Results Webcast And Conference Call 3/13/2014 6:35:32 AM    More...
Xencor To Present At 2014 Leerink Swann and Company Global Healthcare Conference 2/7/2014 6:12:10 AM    More...
Xencor Prices Initial Public Offering 12/3/2013 11:30:47 AM    More...
Xencor Files Registration Statement for Proposed Initial Public Offering 10/11/2013 2:59:57 PM    More...
Autoimmune Biotech Xencor Files for a $69 Million IPO 10/11/2013 7:34:08 AM    More...
MorphoSys AG and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208 (Xmab5574) 10/7/2013 9:44:32 AM    More...
Xencor's XmAb5871 Enters Phase 2a Study for Autoimmune Disease 10/2/2013 9:20:17 AM    More...
123456789